Physician profile
Amber Moore
NPI 1407333156
$1,569.09
in general payments reported to CMS, 2019-2025
17 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $20.61 · 2024: $189 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,360.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $264.60 | 2024-2025 | |
| Boston Scientific Corporation | $232.96 | 2024-2025 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $189.42 | 2021-2025 | |
| Novo Nordisk INC | $156.16 | 2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $123.05 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.66 | 2025 | Lifevest |
| Amgen INC. | $65.51 | 2024-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $53.60 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Atricure, INC. | $47.45 | 2025 | Synergy Ablation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.76 | 2021-2024 | Jardiance |
| Inspire Medical Systems, INC. | $42.00 | 2025 | Inspire |
| Abiomed | $41.52 | 2025 | |
| Pfizer INC. | $40.11 | 2025 | |
| Chiesi USA, INC. | $36.75 | 2025 | Kengreal |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $21.04 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $19.50 | 2025 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.